Accelerated tumor progression in mice lacking the ATP receptor P2X7.
暂无分享,去创建一个
F. Di Virgilio | P. Pinton | N. Jørgensen | M. Bonora | V. Pistoia | L. Abelli | L. Raffaghello | A. Giuliani | L. Emionite | S. Falzoni | A. Franceschini | A. Sarti | E. Adinolfi | M. Capece | S. Syberg | D. Corigliano | Alessandra Rotondo | Marina Capece
[1] M. Wallace,et al. Abstract 2957: Investigating methyl-CpG DNA recognition in cancer , 2015 .
[2] F. Wiklund,et al. Atorvastatin prevents ATP-driven invasiveness via P2X7 and EHBP1 signaling in PTEN-expressing prostate cancer cells. , 2014, Carcinogenesis.
[3] J. Köhl,et al. C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. , 2013, Blood.
[4] D. Quail,et al. Microenvironmental regulation of tumor progression and metastasis , 2014 .
[5] F. Di Virgilio,et al. Purinergic signalling and cancer , 2013, Purinergic Signalling.
[6] F. Di Virgilio,et al. Detecting adenosine triphosphate in the pericellular space , 2013, Interface Focus.
[7] C. Ricordi,et al. Long-Term Heart Transplant Survival by Targeting the Ionotropic Purinergic Receptor P2X7 , 2013, Circulation.
[8] C. Ricordi,et al. Effect of the Purinergic Inhibitor Oxidized ATP in a Model of Islet Allograft Rejection , 2013, Diabetes.
[9] F. Di Virgilio,et al. Purines, purinergic receptors, and cancer. , 2012, Cancer research.
[10] F. Di Virgilio,et al. P2 receptors and immunity , 2012, Microbes and infection.
[11] I. Chessell,et al. Genetic Background Strongly Influences the Bone Phenotype of P2X7 Receptor Knockout Mice , 2012, Journal of osteoporosis.
[12] F. Di Virgilio,et al. P2X7 receptor‐stimulation causes fever via PGE2 and IL‐1β release , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[13] F. Di Virgilio,et al. Expression of P2X7 receptor increases in vivo tumor growth. , 2012, Cancer research.
[14] F. Di Virgilio,et al. Autophagy-Dependent Anticancer Immune Responses Induced by Chemotherapeutic Agents in Mice , 2011, Science.
[15] F. Di Virgilio,et al. The P2X7 Receptor and Pannexin-1 Are Both Required for the Promotion of Multinucleated Macrophages by the Inflammatory Cytokine GM-CSF , 2011, Journal of Immunology.
[16] M. Bours,et al. P2 receptors and extracellular ATP: a novel homeostatic pathway in inflammation. , 2011, Frontiers in bioscience.
[17] C. Dinarello. A clinical perspective of IL‐1β as the gatekeeper of inflammation , 2011, European journal of immunology.
[18] W. Junger,et al. Immune cell regulation by autocrine purinergic signalling , 2011, Nature Reviews Immunology.
[19] M. Idzko,et al. Graft-versus-host disease is enhanced by extracellular ATP activating P2X7R , 2010, Nature Medicine.
[20] F. Di Virgilio,et al. Trophic activity of a naturally occurring truncated isoform of the P2X7 receptor , 2010, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[21] M. Gavala,et al. Extracellular ATP May Contribute to Tissue Repair by Rapidly Stimulating Purinergic Receptor X7-Dependent Vascular Endothelial Growth Factor Release from Primary Human Monocytes , 2010, The Journal of Immunology.
[22] L. Zitvogel,et al. Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. , 2010, Cancer research.
[23] C. Reid,et al. The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore , 2009, The Journal of Neuroscience.
[24] D. Ojcius,et al. The P2X7 receptor and intracellular pathogens: a continuing struggle , 2009, Purinergic Signalling.
[25] J. Lucas,et al. Inhibition of the ATP-gated P2X7 receptor promotes axonal growth and branching in cultured hippocampal neurons , 2008, Journal of Cell Science.
[26] F. Di Virgilio,et al. Increased Level of Extracellular ATP at Tumor Sites: In Vivo Imaging with Plasma Membrane Luciferase , 2008, PloS one.
[27] Geoffrey Burnstock,et al. Physiology and pathophysiology of purinergic neurotransmission. , 2007, Physiological reviews.
[28] D. Ribatti,et al. Endogenous IL-12 triggers an antiangiogenic program in melanoma cells , 2007, Proceedings of the National Academy of Sciences.
[29] F. Di Virgilio,et al. A role for P2X7 in microglial proliferation , 2006, Journal of neurochemistry.
[30] J. Wiley,et al. Rapid ATP-induced release of matrix metalloproteinase 9 is mediated by the P2X7 receptor. , 2006, Blood.
[31] F. Di Virgilio,et al. Basal activation of the P2X7 ATP receptor elevates mitochondrial calcium and potential, increases cellular ATP levels, and promotes serum-independent growth. , 2005, Molecular biology of the cell.
[32] M. Colombo,et al. Leukocyte, Rather than Tumor-produced SPARC, Determines Stroma and Collagen Type IV Deposition in Mammary Carcinoma , 2003, The Journal of experimental medicine.
[33] M. Seman,et al. Cutting Edge: A Natural P451L Mutation in the Cytoplasmic Domain Impairs the Function of the Mouse P2X7 Receptor1 , 2002, The Journal of Immunology.
[34] C. Gabel,et al. Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response , 2002, The Journal of Immunology.
[35] R. North. Molecular physiology of P2X receptors. , 2002, Physiological reviews.
[36] I. N. Brown,et al. Changes in murine bone marrow macrophages and erythroid burst‐forming cells following the intravenous injection of liposome‐encapsulated dichloromethylene diphosphonate (Cl2MDP) , 2001, European journal of haematology.
[37] F. Virgilio. Dr. Jekyll/Mr. Hyde : the dual role of extracellular ATP , 2000 .
[38] M. Salgaller. American Association for Cancer Research , 2000, Expert opinion on investigational drugs.
[39] F. Di Virgilio,et al. Mouse dendritic cells express the P2X7 purinergic receptor: characterization and possible participation in antigen presentation. , 1999, Journal of immunology.
[40] G Burnstock,et al. Receptors for purines and pyrimidines. , 1998, Pharmacological reviews.
[41] F. Di Virgilio,et al. Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. , 1997, Journal of immunology.
[42] F. Di Virgilio,et al. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. , 1996, Journal of immunology.
[43] R. Steinman,et al. Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor , 1992, The Journal of experimental medicine.
[44] T. Forrester. An estimate of adenosine triphosphate release into the venous effluent from exercising human forearm muscle , 1972, The Journal of physiology.
[45] M. Fujita,et al. Inflammasomes as molecular mediators of inflammation and cancer: potential role in melanoma. , 2012, Cancer letters.
[46] M. Bours,et al. Adenosine 5'-triphosphate and adenosine as endogenous signaling molecules in immunity and inflammation. , 2006, Pharmacology & therapeutics.
[47] M. Remberger,et al. Myeloablative and immunosuppressive properties of treosulfan in mice. , 2006, Experimental hematology.
[48] F. Di Virgilio,et al. Dr. Jekyll/Mr. Hyde: the dual role of extracellular ATP. , 2000, Journal of the autonomic nervous system.
[49] F. Di Virgilio. The P2Z purinoceptor: an intriguing role in immunity, inflammation and cell death. , 1995, Immunology today.